Alzheimer's News Today

Alzheimer's News Today We are dedicated to sharing the latest news, research, and Alzheimer’s disease patient perspectives.

The Alzheimer's Association is urging patients, caregivers, and advocates to "take action now" and support legislation t...
06/06/2025

The Alzheimer's Association is urging patients, caregivers, and advocates to "take action now" and support legislation this awareness month. https://buff.ly/ZKZOeFJ

The new ApoE4 Alzheimer's Alliance plans to advocate on behalf of patients with this gene variant for more supportive U....
05/02/2025

The new ApoE4 Alzheimer's Alliance plans to advocate on behalf of patients with this gene variant for more supportive U.S. policies. https://buff.ly/e12Q0yK

Leqembi has been approved in the European Union for the treatment of certain adults with early Alzheimer's disease and m...
04/21/2025

Leqembi has been approved in the European Union for the treatment of certain adults with early Alzheimer's disease and mild cognitive issues. https://buff.ly/AjWn0ab

Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and d...
04/04/2025

Cassava will stop developing simufilam for Alzheimer’s this year after a Phase 3 trial failed to improve cognition and daily function. https://buff.ly/Tt1gtM9

Early menopause and poor brain-connection health may interact to increase Alzheimer's disease risk in women, a study fou...
03/07/2025

Early menopause and poor brain-connection health may interact to increase Alzheimer's disease risk in women, a study found. https://buff.ly/qSvMAdJ

The U.S. FDA has approved monthly maintenance dosing for Leqembi, a treatment for early Alzheimer’s disease. https://buf...
02/07/2025

The U.S. FDA has approved monthly maintenance dosing for Leqembi, a treatment for early Alzheimer’s disease. https://buff.ly/3Q8mCOs

The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but...
01/03/2025

The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but ADVANCE-2 didn't. https://bit.ly/3W4Heu2

While columnist Ray Burow loves the Christmas season, she had to alter her expectations for it when she was an Alzheimer...
12/09/2024

While columnist Ray Burow loves the Christmas season, she had to alter her expectations for it when she was an Alzheimer's caregiver. https://bit.ly/3OM6bGU

Muna Therapeutics and GSK announced a research partnership to develop new targets for Alzheimer's treatments. https://bi...
12/06/2024

Muna Therapeutics and GSK announced a research partnership to develop new targets for Alzheimer's treatments. https://bit.ly/4f4tHJR

Being started on a smaller dose of the approved early Alzheimer’s therapy Kisunla was found to reduce the risk of ARIA-E...
11/08/2024

Being started on a smaller dose of the approved early Alzheimer’s therapy Kisunla was found to reduce the risk of ARIA-E on imaging scans. https://buff.ly/4egOWrq

Columnist Ray Burow, grieving the loss of her dear friend Richard Allen Farmer, reflects on how he cared for her mother,...
11/04/2024

Columnist Ray Burow, grieving the loss of her dear friend Richard Allen Farmer, reflects on how he cared for her mother, who had Alzheimer's. https://buff.ly/4hC1nRF

Address

University Park, TX

Alerts

Be the first to know and let us send you an email when Alzheimer's News Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Alzheimer's News Today:

Share